Study on the effect of novel coronavirus pneumonia (COVID-19) vaccination in Tangdu Hospital

Study on the effect of COVID-19 vaccination in Tangdu Hospital

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043801

Enrollment

Unknown

Registered

2021-03-02

Start date

2021-03-23

Completion date

Unknown

Last updated

2021-06-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

COVID-19 vaccination population:No (observation)

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. The subjects who had a fixed labor relationship with Tangdu Hospital (the Second Affiliated Hospital of Air Force Military Medical University) completed the vaccination according to the plan; 2. Subjects who can be followed up on schedule and can tolerate the examinations during the follow-up period; 3. Of those who were physically healthy, there were no major diseases and no chronic infectious diseases such as hepatitis B, hepatitis C and HIV.

Exclusion criteria

Exclusion criteria: Subjects who could not receive the follow-up on schedule or could not tolerate the examinations during the follow-up.

Design outcomes

Primary

Measure	Time frame
Neutralizing antibody against SARS-CoV-2;Specific T cell response against SARS-CoV-2;Immune memory against SARS-CoV-2;Adverse reaction;	—

Countries

China

Contacts

Public ContactLian Jianqi

The Second Affiliated Hospital of Air Force Medical University

lianjq@fmmu.edu.cn+86 29-84777452

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026